Recurrent sebaceous carcinoma of the eyelid: Outcome after postoperative reirradiation.

Reply to Letter to the Editor regarding recurrent sebaceous carcinoma of the eyelid: Outcome after postoperative reirradiation.

Letter to the Editor regarding recurrent sebaceous carcinoma of the eyelid: Outcome after postoperative reirradiation.

To the Editor: We read with great interest the case report titled “Recurrent sebaceous carcinoma of the eyelid: Outcome after postoperative reirradiation” authored by Puja Sahai published in the January 2016 issue of Head & Neck. In this case report, “(a) 38-year-old man . . . diagnosed with sebaceous carcinoma of the right lower eyelid” was described. Herein, we seek a correction, in case your...

Forehead galeal pericranial flap for single-staged total upper eyelid reconstruction in sebaceous gland carcinoma excision

PURPOSE To present a successful case of single-staged total upper eyelid reconstruction after sebaceous gland carcinoma excision by using forehead galeal pericranial flap. OBSERVATIONS An 80-year-old female with a progressively enlarged left upper eyelid mass presented with ocular irritation, blurred vision, and gritty sensation despite topical antibiotics treatment. This multinodular mass in...

[HDR 192Ir brachytherapy in treatment of basal cell carcinoma of the lower eyelid and inner angle - our experience].

PURPOSE First experience and evaluation of relapses in group of patients after surgery with applied adjuvant HDR brachytherapy for recurrent tumor after incomplete excision of basal cell carcinoma of the lower eyelid and inner angle. METHODS Patients with recurrent basal cell carcinoma of the lower eyelid in year 2010. In 3 male patients with recurrent finding of basal cell after surgery we a...

Sebaceous carcinoma of the eyelid: a clinicopathological study.

BACKGROUND Sebaceous carcinoma of the eyelid is rare. The diagnosis might be difficult because of its ability to masquerade as other periocular lesions. Prognosis is still regarded as being poor compared with most other malignant eyelid tumours with a mortality second only to malignant melanoma. The present study retrospectively analyses clinical and histopathological findings and outcome in a ...